Supplemented Infant Formula and Human Breast Milk Show Similar Patterns in Modulating Infant Microbiota Composition and Function In Vitro
International Journal of Molecular Sciences · 02.02.2024 · 25 (3) · 1806
DOI: 10.3390/ijms25031806 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.02.2024. Verfasst von Klaudyna Borewicz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mead Johnson B.V., Middenkampweg 2, 6545 CJ Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Microbiota, Bifidobacterium animalis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mead Johnson Nutrition (Hong Kong) LTD..
Abstract (Originalsprache)
The gut microbiota of healthy breastfed infants is often dominated by bifidobacteria. In an effort to mimic the microbiota of breastfed infants, modern formulas are fortified with bioactive and bifidogenic ingredients. These ingredients promote the optimal health and development of infants as well as the development of the infant microbiota. Here, we used INFOGEST and an in vitro batch fermentation model to investigate the gut health-promoting effects of a commercial infant formula supplemented with a blend containing docosahexaenoic acid (DHA) (20 mg/100 kcal), polydextrose and galactooligosaccharides (PDX/GOS) (4 g/L, 1:1 ratio), milk fat globule membrane (MFGM) (5 g/L), lactoferrin (0.6 g/L), and Bifidobacterium animalis subsp. lactis, BB-12 (BB-12) (106 CFU/g). Using fecal inoculates from three healthy infants, we assessed microbiota changes, the bifidogenic effect, and the short-chain fatty acid (SCFA) production of the supplemented test formula and compared those with data obtained from an unsupplemented base formula and from the breast milk control. Our results show that even after INFOGEST digestion of the formula, the supplemented formula can still maintain its bioactivity and modulate infants’ microbiota composition, promote faster bifidobacterial growth, and stimulate production of SCFAs. Thus, it may be concluded that the test formula containing a bioactive blend promotes infant gut microbiota and SCFA profile to something similar, but not identical to those of breastfed infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mead Johnson B.V., Middenkampweg 2, 6545 CJ Nijmegen, The Netherlands.
- Institute for Life Technologies, University of Applied Sciences Western Switzerland Valais-Wallis, 1950 Sion, Switzerland.
ORCID-Profile: Wolfram Manuel Brück
Förderung
- Mead Johnson Nutrition (Hong Kong) LTD.
Zitieren
APA
Borewicz, K., & Brück, W. M. (2024). Supplemented Infant Formula and Human Breast Milk Show Similar Patterns in Modulating Infant Microbiota Composition and Function In Vitro. International Journal of Molecular Sciences, 25(3), 1806. https://doi.org/10.3390/ijms25031806
Vancouver
Borewicz K, Brück WM. Supplemented Infant Formula and Human Breast Milk Show Similar Patterns in Modulating Infant Microbiota Composition and Function In Vitro. International Journal of Molecular Sciences. 2024;25(3):1806. doi:10.3390/ijms25031806
BibTeX
@article{Borewicz2024,
author = {Borewicz, Klaudyna and Brück, Wolfram Manuel},
title = {Supplemented Infant Formula and Human Breast Milk Show Similar Patterns in Modulating Infant Microbiota Composition and Function In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1806},
doi = {10.3390/ijms25031806}
}
EUVIMED